Powered by: Motilal Oswal
05-09-2023 12:36 PM | Source: LKP Securities Ltd
View on Mankind Pharma IPO from S Ranganathan, LKP Securities
News By Tags | #607 #442 #2951 #6603 #4287

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Below is View on Mankind Pharma IPO by S Ranganathan, Head of Research at LKP Securities

 

Fast Growing India Centric Mankind Pharma truly deserves credit for bringing back life into the Primary Market during CY 2023 with a stellar listing which provided a 30% return to Retail Investors and the icing on the cake was the allotment itself wherein almost all retail investors were allotted the shares.

 

Above views are of the author and not of the website kindly read disclaimer